A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes

Figure 2

Fed plasma glucose over time in low (a) and high (b) fat-fed mice treated with three consecutive once-daily doses of vehicle or 30, 50, or 75 mg/kg STZ. 16-hour fasted plasma glucose (c) and insulin (d) levels four weeks after vehicle or STZ treatments. Treatment groups are denoted as follows: low fat—vehicle, open circles (); low fat—30 mg/kg STZ, open squares (); low fat—50 mg/kg STZ, open triangles (); high fat—vehicle, closed circles (); high fat—30 mg/kg STZ, closed squares (); high fat—50 mg/kg STZ, closed triangles (); and high fat—75 mg/kg STZ, × (). Data are . versus high fat—vehicle.

(a)

(b)

(c)

(d)